Sippican Capital Advisors - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sippican Capital Advisors ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$165,281
-87.0%
10,684
-86.8%
0.15%
-87.3%
Q2 2023$1,269,352
-6.3%
80,799
-1.7%
1.17%
-9.6%
Q1 2023$1,355,233
+5.6%
82,2350.0%1.30%
+5.6%
Q4 2022$1,283,000
+13.1%
82,235
-6.0%
1.23%
+3.7%
Q3 2022$1,134,000
-6.1%
87,460
+1.6%
1.18%
-1.3%
Q2 2022$1,208,000
+4.8%
86,045
+6.9%
1.20%
+25.3%
Q1 2022$1,153,000
+21.6%
80,490
+15.7%
0.96%
+18.9%
Q4 2021$948,000
+33.5%
69,550
+60.5%
0.80%
+30.9%
Q3 2021$710,000
+312.8%
43,320
+324.3%
0.62%
+310.0%
Q2 2021$172,00010,2100.15%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders